Mimedx (MDXG) Times Interest Earned (2011 - 2026)
Mimedx (MDXG) reported Times Interest Earned of -$39.92 for Q1 2026, down 396.12% on a YoY basis from $13.48 in Q1 2025, and down 234.86% sequentially from $29.6 in Q4 2025.
Mimedx (MDXG) Times Interest Earned (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 16 years of Times Interest Earned data on file, last reported at -$39.92 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 396.12% year-over-year to -$39.92; the trailing twelve-month figure through Mar 2026 stood at $14.09 (down 84.0% YoY), and the FY2025 full-year result was $5.76, down 61.44% from the prior year.
- Times Interest Earned slipped to -$39.92 in Q1 2026, from $29.6 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $30.36 in Q3 2025 to a low of -$39.92 in Q1 2026.
- A 5-year average of $3.13 and a median of $6.23 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned plunged 747.26% in 2022 and jumped 2474.19% in 2024, its largest moves.
- Tracing MDXG's Times Interest Earned over 5 years: stood at $6.23 in 2022, then slumped by 186.88% to -$5.41 in 2023, then sank by 200.69% to -$16.28 in 2024, then soared by 281.84% to $29.6 in 2025, then plunged by 234.86% to -$39.92 in 2026.
- Business Quant data shows MDXG's Times Interest Earned at -$39.92 in Q1 2026, $29.6 in Q4 2025, and $30.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -39.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.92 |
| Dec 31, 2025 | 29.60 |
| Sep 30, 2025 | 30.36 |
| Jun 30, 2025 | 19.60 |
| Mar 31, 2025 | 13.48 |
| Dec 31, 2024 | -16.28 |
| Sep 30, 2024 | 6.36 |
| Jun 30, 2024 | 13.59 |
| Mar 31, 2024 | 5.56 |
| Dec 31, 2023 | -5.41 |
| Sep 30, 2023 | 6.61 |
| Jun 30, 2023 | 7.20 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | 6.23 |
| Sep 30, 2022 | -6.17 |
| Jun 30, 2022 | -9.24 |
| Mar 31, 2022 | -8.14 |
| Dec 31, 2021 | 1.21 |
| Sep 30, 2021 | -1.02 |
| Jun 30, 2021 | -1.09 |